Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Accured Expenses (2023 - 2025)

Camp4 Therapeutics' Change in Accured Expenses history spans 3 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 34.93% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $805000.0, down 47.42%, while the annual FY2025 figure was $805000.0, 47.42% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.2 million at Camp4 Therapeutics, down from $1.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.8 million in Q4 2024 and bottomed at -$2.8 million in Q1 2025.
  • The 3-year median for Change in Accured Expenses is $717000.0 (2024), against an average of $322000.0.
  • The largest annual shift saw Change in Accured Expenses surged 227.58% in 2024 before it plummeted 721.88% in 2025.
  • A 3-year view of Change in Accured Expenses shows it stood at $562000.0 in 2023, then soared by 227.58% to $1.8 million in 2024, then crashed by 34.93% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Change in Accured Expenses are $1.2 million (Q4 2025), $1.4 million (Q3 2025), and $1.0 million (Q2 2025).